Drug Shortage Report for OLANZAPINE FOR INJECTION
| Report ID | 116949 |
| Drug Identification Number | 02416522 |
| Brand name | OLANZAPINE FOR INJECTION |
| Common or Proper name | OLANZAPINE FOR INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OLANZAPINE |
| Strength(s) | 10MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1PSOIJ |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-06-05 |
| Estimated end date | Unknown |
| Actual end date | 2023-07-28 |
| Shortage status | Resolved |
| Updated date | 2023-11-17 |
| Company comments | Discontinuation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-11-17 | French | Compare |
| v3 | 2023-11-17 | English | Compare |
| v2 | 2020-06-08 | French | Compare |
| v1 | 2020-06-08 | English | Compare |
Showing 1 to 4 of 4